In addition, compared with that of patients in the SHCBP1 low-expression group, the survival prognosis of LUAD patients in the SHCBP1 high-expression group who received radiotherapy was worse, indicating that lung cancer patients with low SHCBP1 expression are more sensitive to radiotherapy. This evidence concerns the gene SHCBP1 and lung cancer.